CDKN2A and meningioma: Besides 1p deletion, losses of chromosome 6q, 10, 17q and 18q, mutations of the TERT promoter or homozygous deletions of CDKN2A/B are described to influence the clinical course in meningioma patients [3, 5, 12, 30].